DelveInsight has launched a new report on “Rosacea – Market Insights, Epidemiology, and Market Forecast-2030”.
DelveInsight’s “Rosacea – Market Insights, Epidemiology, and Market Forecast-2030″ report delivers an in-depth understanding of the Rosacea, historical and forecasted epidemiology as well as the Rosacea market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan.
Some of the key facts of the Rosacea Market Report:
As per a study by Tan et al. (2016), titled “Prevalence of rosacea in the general population of Germany and Russia – The RISE study,” a total of 3,052 and 3,013 subjects (aged 18–65 years) were screened in Germany and Russia respectively. Rosacea prevalence was 12.3% in Germany. Overall, 18% of subjects diagnosed with rosacea were aged 18–30 years. Demographics of rosacea subjects with a confirmed diagnosis were similar in Germany and Russia. In Germany, 74.4% (61/82) were females. In Germany, erythematotelangiectatic, papulopustular, phymatous, and ocular subtypes were found in 69.5% (57/82), 30.5% (25/82), 4.9% (4/82), and 7.3% (6/82) of patients.
Key benefits of the report:
Rosacea market report covers a descriptive overview and comprehensive insight of the Rosacea Epidemiology and Rosacea market in the 7MM (the United States, EU5 (Germany, Spain, France, Italy, UK) & Japan.)
The Rosacea market report provides insights on the current and emerging therapies.
Rosacea market report provides a global historical and forecasted market covering drug outreach in 7MM.
The Rosacea market report offers an edge that will help in developing business strategies by understanding trends shaping and driving the Rosacea market.
Rosacea is a characteristic condition that affects the skin by causing facial erythema or redness. Around one in 10 people in the world is affected by rosacea. The symptoms of the disease manifest in various combinations and severity, which often fluctuate between periods of exacerbation and remission. It is a common skin condition that causes redness and visible blood vessels in the central part of the face. It may also produce small, red, pus-filled bumps.
The dynamics of the Rosacea market are anticipated to change in the coming years owing to the expected launch of emerging therapies such as Sol-Gel Technologies, Accuitis, AOBiome, and others during the forecasted period 2018-2030.
Learn more by requesting for sample @ Rosacea Market Landscape
Rosacea Pipeline Therapies and Key Companies
Epsolay: Sol-Gel Technologies
Table of Contents
1. Report Introduction
2. Executive Summary
3. SWOT analysis
4. Rosacea Patient Share (%) Overview at a Glance
5. Rosacea Market Overview at a Glance
6. Rosacea Disease Background and Overview
7. Rosacea Epidemiology and Patient Population
8. Country-Specific Patient Population of Rosacea
9. Rosacea Current Treatment and Medical Practices
10. Unmet Needs
11. Rosacea Emerging Therapies
12. Rosacea Market Outlook
13. Country-Wise Rosacea Market Analysis (2018–2030)
14. Market Access and Reimbursement of Therapies
15. Market drivers
16. Market barriers
18. Rosacea Report Methodology
19. DelveInsight Capabilities
21. About DelveInsight
Company Name: DelveInsight Business Research LLP
Contact Person: Kritika Rehani
Email: Send Email
Address:304 S. Jones Blvd #2432
City: Las Vegas
Country: United States